ProMetic Life Sciences Inc. (PLI) 2002年年度报告「TSX」.pdf

1、2002Annual ReportEnabling a worldof better healthCorporate profileEnabling a World ofBetter Health for AllProMetic is a leading biopharmaceutical company engaged in thedevelopment,manufacture and commercialization of products forthe biopharmaceutical industry.ProMetics goal is to enable further impr

2、ovements to well-established therapies aswell as to create better and more efficient technologies for new drugs and diseasetreatments.In so doing,ProMetic will be helping people in developed and developingcountries around the world lead healthier lives,while at the same time creatingethical financia

3、l opportunities for shareholders.ProMetics proprietary technology is key to the development and manufactureof proteins.It has commercial applications in a wide range of areas,from proteomicsto industrial biopharmaceutical manufacturing,and from blood product safety todiagnostics and therapeutics.Pha

4、rmaceutical and biotechnology companies use ProMetics technology andproducts,through licensing agreements,to develop and manufacture their own products.ProMetic further leverages its core technologies and competencies bydeveloping proprietary,value-added therapeutics and medical devices.Clinicaldeve

5、lopment and marketing risks are shared through partnerships withmultinational companies.Founded in 1994,ProMetic Life Sciences Inc.along with its subsidiaries has102 employees with R&D facilities in Montreal(Canada)and Cambridge(UK),manufacturing facilities in Canada and in the UK,and marketing pres

6、ence inEurope,USA and Japan.Chemical Combinatorial LibraryMimetic LigandSynthetic compounds designedto bind to a specific protein(like antibody-antigen interaction)PurabeadbeadsPerfluorosorbbeads(Teflon)Immobilize ligands onto particlesCapture targeted proteinDetectScreeningDiagnosticPurifyPurificat